Wu, Jincheng
9Novartis Institute for Biomedical Research, Cambridge, Massachusetts.
2 papers on CoChatORCID 0000-0002-4465-8424
Most cited papers
- Verified
Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Meric-Bernstam, F., Sweis, R. F., Hodi, F. S., Messersmith, W. A., Andtbacka, R. H. I., Ingham, M., Lewis, N., Chen, X., Pelletier, M., Chen, X., et al. (2022) · Clinical Cancer Research
interferon and immune responsesImmunotherapy and Immune Responses
Cited by 418
- Verified
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
Grauel, A. L., Nguyen, B., Ruddy, D., Laszewski, T., Schwartz, S., Chang, J., Chen, J., Piquet, M., Pelletier, M., Yan, Z., et al. (2020) · Nature Communications
TGF-β signaling in diseasesCancer Cells and Metastasis
Cited by 211
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free